Patents by Inventor Clinton S. Robison

Clinton S. Robison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR MAGNETIC RESONANCE IMAGING
    Publication number: 20120021450
    Abstract: In certain aspects the present invention provides methods and compositions related to contrast agents for magnetic resonance imaging. In certain variations, contrast agents provided herein are generated in situ via genetic instructions and become potent upon sequestering available metal atoms. Exemplary contrast agents include metal-binding proteins.
    Type: Application
    Filed: July 18, 2011
    Publication date: January 26, 2012
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Eric T. Ahrens, Clinton S. Robison
  • Methods for magnetic resonance imaging
    Patent number: 7998704
    Abstract: In certain aspects the present invention provides methods and compositions related to contrast agents for magnetic resonance imaging. In certain variations, contrast agents provided herein are generated in situ via genetic instructions and become potent upon sequestering available metal atoms. Exemplary contrast agents include metal-binding proteins.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: August 16, 2011
    Assignee: Carnegie Mellon University
    Inventors: Eric T. Ahrens, Clinton S. Robison
  • Recombinant viruses comprising the membrane-proximal domain of VSV G protein
    Patent number: 7994295
    Abstract: Recombinant viruses, isolated nucleic acids and methods of generating same encoding for a Rhabdoviral G stem polypeptide are disclosed. Methods, compounds and compositions for target cell fusion potentiation mediated by Rhabdoviral G stem polypeptides, and applications of same are provided.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: August 9, 2011
    Assignee: The University of Tennessee Research Corporation
    Inventors: Michael A. Whitt, Clinton S. Robison
  • Recombinant viruses comprising the membrane-proximal domain of VSV G protein
    Publication number: 20100167377
    Abstract: Recombinant viruses, isolated nucleic acids and methods of generating same encoding for a Rhabdoviral G stem polypeptide are disclosed. Methods, compounds and compositions for target cell fusion potentiation mediated by Rhabdoviral G stem polypeptides, and applications of same are provided.
    Type: Application
    Filed: December 23, 2002
    Publication date: July 1, 2010
    Inventors: Michael A. Whitt, Clinton S. Robison
  • Recombinant Rhabdovirus containing a heterologous fusion protein
    Publication number: 20030138457
    Abstract: This invention relates to a composition comprising a recombinant or genetically engineered Rhabdovirus that expresses a Fusion Protein, such as the F protein of the Paramyxovirus SV5 strain. This recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein. The invention also relates to methods of making recombinant Rhabdoviruses which express an F Protein. These recombinant compositions can be used for purposes of research, as well as for diagnostic and therapeutic compositions for treatment of diseases.
    Type: Application
    Filed: October 23, 2002
    Publication date: July 24, 2003
    Inventors: Michael A. Whitt, Clinton S. Robison
  • Recombinant Rhabdovirus containing a heterologous fusion protein
    Patent number: 6497873
    Abstract: This invention relates to a composition comprising a recombinant or genetically engineered Rhabdovirus that expresses a Fusion Protein, such as the F protein of the Paramyxovirus SV5 strain. This recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein. The invention also relates to methods of making recombinant Rhabdoviruses which express an F Protein. These recombinant compositions can be used for purposes of research, as well as for diagnostic and therapeutic compositions for treatment of diseases.
    Type: Grant
    Filed: December 22, 1998
    Date of Patent: December 24, 2002
    Assignee: The University of Tennessee Research Corporation
    Inventors: Michael A. Whitt, Clinton S. Robison